A study on vancomycin treatment, new data on the investigational Pfizer C diff vaccine, how individual antibiotics are ranked by risk for C difficile infection, and more.
The Latest in Clostridioides difficile Research and News
C difficile, Antimicrobials, and the Patients Most Affected
Oral Vancomycin Reduces CDI by 64% in Stem Cell Transplant Patients
Top 5 Infectious Disease News Stories Week of November 8-15
Head-to-Head Comparison of Treatments for Recurrent C difficile Infection
Top 5 Infectious Disease New Stories Week of November 2-8